Crossmark

Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey

Crossref DOI link: https://doi.org/10.1007/s00228-018-2460-2

Published Online: 2018-04-14

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moulis, Florence

Rousseau, Vanessa

Chebane, Leila

Gouverneur, Amandine

Gaboriau, Louise

Faillie, Jean-Luc

Durrieu, Geneviève

Montastruc, François

Montastruc, Jean-Louis
License Information

Text and Data Mining valid from 2018-04-14
More Information

Article History

Received: 20 December 2017

Accepted: 4 April 2018

First Online: 14 April 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The content of this article only involved the authors and the opinions and conclusions are not necessary those of ANSM (Agence Nationale de Sécurité du Médicament et des produits de santé). Authors of this article are solely responsible for the conclusions.